Retail sales of prescription pharmaceutical products in the world's 10 leading markets reached a total of $139.06 billion (excluding the effects of currency exchange rates) in 1995, an increase of 8% over sales in 1994, according to new figures published last week by IMS International. Sales growth for 1994 had been 5%.
Sales in the USA were above-average for the year, growing 10% to $54.7 billion, but the fastest growth out of the 10 markets monitored by IMS was reported for Spain, which grew 11% to reach $4.76 billion. The UK market reported an advance of 9% to reach $6.24 billion, while retail sales in belgium increased 8% to $1.98 billion, turnover in Germany was up 7% to $16.51 billion, France advanced 6% to $15.11 billion and the Netherlands rose 5% to total $2.07 billion. Overall growth for the top seven European markets was 7%, reaching a combined figure of $54.35 billion.
Prescription drug sales in japan, excluding the hospital sector) rose 8% to $26.44 billion, and in Canada they were up 4% to $3.55 billion.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze